Search Results
Nov 05, 2025, 16:12 ET StemCyte Launches First Insurance-Linked Public Cord Blood Access in Taiwan, Setting a New Standard in Cell Therapy Protection
and clinical leadership. Worldwide, allogeneic cord blood transplantation has supported the treatment of over 80 hematologic, immune, metabolic, and rare diseases. With a record of more than 2,300 successful transplants, StemCyte has become one of the most experienced providers
More news about: StemCyte
Nov 05, 2025, 16:05 ET Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights
low-grade upper tract urothelial carcinoma (SURF303) and potentially future mUC clinical trials. The FDA has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation to dabogratinib for the treatment of achondroplasia. BEACH301 is a Phase 2, multicenter,
More news about: Tyra Biosciences
Nov 05, 2025, 16:05 ET Lucid Announces Third Quarter 2025 Financial Results
products and services and cancellation of orders for Lucid's vehicles; risks related to prices and availability of commodities and materials, including rare earth minerals and semiconductors and its related products, Lucid's supply chain, logistics, inventory management and quality control, and Lucid's ability
More news about: Lucid Group
Nov 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance
on August 6, ensuring patients with H3 K27M-mutant diffuse midline glioma (DMG) had access to the first and only targeted drug therapy for this ultra-rare and aggressive brain tumor. Modeyso was included in the NCCN® Clinical Practice
More news about: Jazz Pharmaceuticals plc
Nov 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance
on August 6, ensuring patients with H3 K27M-mutant diffuse midline glioma (DMG) had access to the first and only targeted drug therapy for this ultra-rare and aggressive brain tumor. Modeyso was included in the NCCN® Clinical Practice
More news about: Jazz Pharmaceuticals plc
Nov 05, 2025, 14:55 ET Volcan de mi Tierra Partners With The Only Caviar and TY Bar At The Four Seasons Hotel New York
said, "TY Bar is passionate about creating experiences that invite our guests to explore flavor in unexpected and memorable ways. The 6th Taste was a rare opportunity to celebrate the artistry of both Volcan de mi Tierra and The Only Caviar, a union of heritage, innovation and indulgence. We are honored
More news about: Volcan de mi Tierra
Nov 05, 2025, 12:03 ET New environmental DNA test could help rare hammerhead sharks fight extinction
multimedia:https://www.prnewswire.com/news-releases/new-environmental-dna-test-could-help-rare-hammerhead-sharks-fight-extinction-302605935.html
More news about: Florida International University
Nov 05, 2025, 11:53 ET My Plates Unveils 2025 Great Plate Auction Showcasing 50 Unique Plate Messages.
this auction welcomes YAAALL to explore some EXTREME and unique messages that may WOW you. Up for grabs are rare two-number and two-letter plate combinations like 12 and MB, to sports team plates like COWBOY5 and COUGRS, to Texas-themed
More news about: MyPlates.com
Nov 05, 2025, 11:45 ET New ALS Association Co-Authored Study Projects Dramatic Increase in Prevalence by 2040
would jump to 12.01 per 100,000 people. "These findings suggest that ALS, which is generally classified as a rare disease, will affect an increasingly larger share of the population worldwide in the coming decades, with important implications for health care planning,
More news about: The ALS Association
Nov 05, 2025, 11:36 ET Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week
switched from placebo experienced similar improvements. This demonstrates the potential of Aspaveli/Empaveli to transform care for people living with these rare diseases, who have a high risk of kidney failure," said Lydia Abad-Franch, MD, Head of R&D and Medical Affairs, and Chief Medical Officer at Sobi.
More news about: Swedish Orphan Biovitrum AB
Nov 05, 2025, 11:10 ET The Halpern Law Firm Proudly Sponsors the 2025 International Mesothelioma Interest Group (iMig) Conference
mesothelioma. Sponsoring iMig 2025 reflects the firm's continued dedication to supporting both legal advocacy and medical advancement in the fight against this rare cancer. About The Halpern Law Firm The Halpern Law Firm has offices all over Pennsylvania, and is devoted
More news about: The Halpern Law Firm, LLC
Nov 05, 2025, 10:49 ET Ultra-Rare WWII German Enigma Machine: A Masterpiece of Military Codebreaking History Heads to Auction
multimedia:https://www.prnewswire.com/news-releases/ultra-rare-wwii-german-enigma-machine-a-masterpiece-of-military-codebreaking-history-heads-to-auction-302605848.html
More news about: Rock Island Auction Company
Nov 05, 2025, 10:01 ET Critical Minerals Market to Reach USD 586.63 Billion by 2032, Driven by Energy Transition and Electric Mobility Demand | DataM Intelligence
Key Players: Albemarle Corporation | Livent Corporation | Lynas Rare Earths Limited | MP Materials Corp. | China Northern Rare Earth (Group) High-Tech Co., Ltd. | Glencore plc | Iluka Resources Limited | Rio Tinto Group | Pilbara Minerals Limited
More news about: DataM Intelligence 4 Market Research LLP
Nov 05, 2025, 10:00 ET GitLaw launches AI agent to make legal documents free for millions of businesses and announces $3M pre-seed led by Jackson Square Ventures
traditional legal help. GitLaw is tackling that gap with a product that's as transformative as it is accessible. "Nick has a rare combination of technical depth and market vision and we have no doubt he'll drive GitLaw to be the go-to legal infrastructure for this part of the market."
More news about: GitLaw
Nov 05, 2025, 09:15 ET StockX Introduces "StockX Auctions," A Premium Bidding Experience for the World's Most Sought-After Current Culture Collectibles
Inaugural auction features ultra-rare Nike Dunk Low Off-White Futura Syracuse with carrying case, and legendary Nike Mag sneakers Bidding starts at $1, with no reserve,
More news about: StockX
Nov 05, 2025, 09:10 ET Brassfield Estate Winery Celebrates Successful 2025 Harvest Season
Volcano, welcoming visitors from all over the United States. Located in the High Valley AVA of Lake County, Brassfield Estate Winery is perched at a rare altitude shared by only 1% of vineyards worldwide. Renowned for its commitment to precision and sustainable farming, the estate produces seventeen varietal
More news about: Brassfield Estate Winery
Nov 05, 2025, 09:00 ET CommanderAI Raises $5 Million Seed Round to Bring AI-Powered Sales to the Waste Management Industry
an easy decision." "In an industry where adoption is typically slow, the speed and intensity of CommanderAI's customer pull is rare to see," said Devon O'Rourke, Founder & Managing Partner, Fluvio Ventures. "Unlike Salesforce or HubSpot, Commander was purpose-built for the fragmented,
More news about: CommanderAI
Nov 05, 2025, 08:57 ET LaserAway, Nation's Largest Aesthetic Dermatology Brand, Opens 200th Clinic
precedes the company's 20th anniversary, which takes place this January, and reflects two decades of continuous growth without a single clinic closure, a rare achievement in retail and the medical aesthetics category.
More news about: LaserAway
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
100 years in diabetes care. Building on this foundation, our purpose is to drive change to defeat serious chronic diseases — from diabetes and obesity to rare blood and endocrine disorders — by pioneering scientific breakthroughs, expanding access to medicines, and working to prevent and ultimately cure disease.
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
100 years in diabetes care. Building on this foundation, our purpose is to drive change to defeat serious chronic diseases — from diabetes and obesity to rare blood and endocrine disorders — by pioneering scientific breakthroughs, expanding access to medicines, and working to prevent and ultimately cure disease.
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:00 ET Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
The ODD was created under the Orphan Drug Act, a law passed by Congress in 1983 that incentivizes the development of drugs to treat rare diseases. Rare disease is defined as affecting fewer than 200,000 individuals in the United States. The ODD request requires evidence demonstrating potential
More news about: Calico Life Sciences LLC
Nov 05, 2025, 08:00 ET Track Rabbit Doubles Down: AI Investment, Organizer-Driven Impact
listens to its clients. Every update, every feature feels like it was created to solve real challenges we face day to day. That kind of attention is rare in this industry. [Plus,] Track Rabbit's pricing structure makes it possible for smaller organizations like ours to operate sustainably and still offer
More news about: Track Rabbit
Nov 05, 2025, 08:00 ET Procurement Sciences Closes $30 Million Series B to Accelerate AI Platform Helping Businesses Find, Win and Deliver Government Contracts
months can now be drafted in minutes – tailored, compliant and ready for review. "Procurement Sciences has achieved something rare – true category creation in a massive, underserved market," said Tyler Newton, managing partner at Catalyst Investors, who has joined the Procurement
More news about: Procurement Sciences
Nov 05, 2025, 08:00 ET Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache
pressureMedication overuse headache: Detoxification may be necessaryPreterm labor: Advise pregnant women of the riskFibrotic complications: Rare cases have been reported following prolonged daily use of dihydroergotamine mesylate. Administration of Atzumi™ should not exceed the dosing guidelines
More news about: Satsuma Pharmaceuticals, Inc.
Nov 05, 2025, 07:04 ET RAMACO RESOURCES, INC. PRICES HEDGING TRANSACTION TO PLACE BORROWED CLASS A COMMON STOCK IN CONNECTION WITH CONVERTIBLE NOTES OFFERING
Mine will be converted into mineral reserves in the future. Rare earth elements and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities. Any forward-looking statement speaks only
More news about: Ramaco Resources, Inc.